| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 275 |
| 1 | METHOTREXATE SODIUM | 268 |
| 2 | DENOSUMAB | 264 |
| 3 | METHOTREXATE | 223 |
| 4 | ADALIMUMAB | 189 |
| 5 | PREDNISOLONE | 146 |
| 6 | PREDNISOLONE ORAL | 146 |
| 7 | PREDNISOLONE ORAL SOLUTION | 146 |
| 8 | TOCILIZUMAB | 140 |
| 9 | ABATACEPT | 133 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SILTUXIMAB | 9 | 0.0139 |
| 1 | RALTEGRAVIR | 36 | 0.0069 |
| 2 | BARICITINIB | 15 | 0.0049 |
| 3 | SATRALIZUMAB | 8 | 0.0045 |
| 4 | ERGOCALCIFEROL | 100 | 0.0034 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 9 | 0.0032 |
| 6 | NELFINAVIR MESYLATE | 6 | 0.0029 |
| 7 | DARUNAVIR ETHANOLATE AND COBICISTAT | 5 | 0.0028 |
| 8 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 18 | 0.0027 |
| 9 | IBANDRONATE SODIUM | 8 | 0.0025 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lead Chelator [EPC] | 2 | 0.0238 |
| 1 | Interleukin-6 Antagonist [EPC] | 9 | 0.0139 |
| 2 | Antidiarrheal [EPC] | 2 | 0.0084 |
| 3 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 4 | Provitamin D2 Compound [EPC] | 100 | 0.0034 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 169 | 0.0015 |
| 6 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 80 | 0.0013 |
| 9 | RANK Ligand Inhibitor [EPC] | 264 | 0.0013 |